|Therapies for Pediatric Patients with Sickle Cell Disease|
Lanetta Bronté-Hall, MD, MPH, MSPH, and Andrew Campbell, MD
|Release Date: October 25, 2021|
Expiration Date: October 25, 2022
In this activity, two experts discuss the care of pediatric patients with sickle cell disease, including updated information on therapies. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care.Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Novartis Pharmaceuticals.
|View Only, No Credit|